{ "items": [ "\n\n
What is it like to study in Oxford in the midst of a pandemic? Check out this video of our IHTM MSc student Greco Malijan's impressions of Oxford in the first few months of the course.
\n \n\n \n \nThe MSc in International Health and Tropical Medicine is open to candidates from a variety of academic backgrounds, both medical and non-medical.
\n \n\n \n \nThe MSc in Modelling for Global Health is a full-time one-year taught programme that provides interdisciplinary content on modelling, health evidence to inform the modelling, and policy processes to inform decisions. Week-long modules are delivered through a mix of interactive practical sessions and lectures in person at Oxford. Demand for a skilled workforce in this field is on the rise and there is great potential for mathematical and economic modelling to help guide policy for national health systems and international policymaking.
\n \n\n \n \nOur Intranet has migrated to SharePoint. This information is restricted to our members
\n \n\n \n \nMalaria is a big problem in Africa, but individuals who get repeatedly infected become resistant. As technology improves, we can measure more parameters and better understand how people become immune to malaria. A protein microarray can help us understand the immune response to malaria, paving the way for a vaccine.
\n \n\n \n \nTungiasis is a neglected tropical skin disease caused by the sand flea Tunga penetrans which burrows into the skin. Limited clinical trials have shown that neem and coconut oils cause the fleas to age prematurely, and that silicon-based oils can kill the fleas effectively. More research is needed to develop interventions to control and treat the disease.
\n \n\n \n \nTo improve outcome for critically ill children, healthcare workers need to be trained to better work together. In addition, guidelines are often quite strict but not always tested by clinical trials. Fluid interventions for critically ill children with severe malaria or sepsis in African hospitals actually worsen the outcome. Researchers working in large consortia can also make better impact for patients and to policy makers.
\n \n\n \n \n